David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
Graphite Bio, a startup biotech company, has raised $45 million in an initial financing round to advance its gene editing technology to treat sickle cell disease and other genetic conditions. ... Read more
Emotional distress affected nearly half of the parents caring for adolescents with sickle cell disease in a recent study, with greater numbers of hospital visits and other life disruptions predicting ... Read more
Taking vitamin D supplements may lower the number of visits to the emergency department due to vaso-occlusive pain episodes in African American children with sickle cell disease (SCD), a study found. The findings ... Read more
The U.S. National Institutes of Health (NIH) has awarded researchers at Rice University a four-year, $2.45-million grant to support the development of a CRISPR/Cas9-based gene editing treatment for sickle ... Read more
The nonprofit HealthWell Foundation launched a new fund to help people with sickle cell disease afford their treatments. Awards will provide up to $10,000 over 12 months to eligible patients ... Read more